chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Wednesday received flu shot; Thursday into Friday arm sore and then neck glands swollen.  Friday developed fever of 100 and nauseous.  Saturday headache and nerve-like pain from neck to spinal cord.
Sore arm - no inflammation, loss of muscle use - weakness, headaches. Constant arm pain, difficulty lifting even a cup of coffee.
Heart attack; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 08Apr2021 (Lot Number: ER8734) as 1st dose, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received his first dose on 08Apr2021 but he missed the second dose which was supposed to be on 29Apr2021 because he had a heart attack after the first dose or in between the doses he did not get the second dose in Apr2021. The patient stated that he needed to set up his 2nd shot. The event outcome was unknown.  Information on Lot/Batch number has been requested.
Mild fever; Aches; This is a spontaneous report from a non-contactable consumer (patient). A patient of an unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 30Mar2021 as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. On unknown date in 2021, the patient experienced mild fever and aches. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch cannot be obtained.
Received Varivax 5/9/02. Developed clinical varicella 9/20/02. No fever or complications. Less than 20 pox lesions.
This spontaneous report was received from a physician via company representatives and refers to a patient of unknown age and gender. The patient's medical history, concurrent condition or concomitant therapies were not reported. On 11-DEC-2014, the patient was vaccinated orally with a dose of 2 ml of ROTATEQ 10 unit dose tube, lot # K000487, expiration date 27-SEP-2015. This vaccine was improperly stored exposed to two temperature excursions, one for a sum of 48 hours with a lowest temperature recorded as 1 degree C and other for a sum of 72 hours with a highest temperature recorded as 9 degrees C. The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator(R)". No adverse effects were reported. There was no product quality complain involved. This is one of several reports received from the same reporter. Additional information has been requested.
She noted fever (above 102), myalgias and arm pain about 14 hours after her vaccines. On exam about 24 hours after the vaccines, the anterior injection site was more tender and slightly edematous. This was the site of the pneumovax vaccine. When viewed the next day, the upper arm was slightly edematous, but not warm an no erythema.
Patient went to COVID vaccine clinic and was administered Janssen COVID 19 vaccination lot# 1802068 at 0800.  About 14 minutes following vaccination developed a diffuse erythematous blotchy rash across her chest and arms. Did complain of burning to her skin.  Patient did not have any shortness of breath or difficutly in breathing.  She was given 50mg of PO benadryl and transferred to the ER for further care.  While in the ER the patient was given 20mg of IV famotidine and 125mg of IV solumedrol.  Patient was discharged from ER about an hour later - her symptoms had completely resolved - she was advised to continue Benadryl 50mg every 6 hours for the next 24 hours by the ER provider.
Booster dose given patient reported had knot in her arm after and reported to pharmacy this month; however she stated was seeing physician due to pain in her left arm prior to reporting adverse event to pharmacy.
hardness in the injection site; rash in the injection site; redness in the injection site; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hardness in the injection site), VACCINATION SITE RASH (rash in the injection site), VACCINATION SITE ERYTHEMA (redness in the injection site) and HEADACHE (headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. (77/11)20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE INDURATION (hardness in the injection site), VACCINATION SITE RASH (rash in the injection site), VACCINATION SITE ERYTHEMA (redness in the injection site) and HEADACHE (headache). At the time of the report, VACCINATION SITE INDURATION (hardness in the injection site), VACCINATION SITE RASH (rash in the injection site), VACCINATION SITE ERYTHEMA (redness in the injection site) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment for the event included Tylenol, Ibuprofen and icing the injection site.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient had redness and soreness at the site of injection. Patient states she went to an urgent care center where they say she had cellulitis.
RED, SWOLLEN ARM (THE SIZE OF A BAKED POTATO). FEVER ON 9/29/2021. PATIENT TOOK TYLENOL AND BENADRYL, NO FEVER ON 9/30/2021
The day after my second dose, I developed what I have seen called "COVID arm" or "Moderna arm," a large, circular rash around the injection site. I developed this reaction one week after my first dose, and again one day after my second dose. The rash was approximately 4 inches in diameter, red, painful, hot to the touch, and significantly swollen. As with the first dose, I felt a 'hard' lump underneath the rash at the injection site. The rash remained red, hot, painful, and swollen for approximately four days. Since then, the affected area has returned to normal. I also felt very ill for around twelve hours, beginning about 26 hours after my second dose. Those symptoms included brain "zaps" similar to a missed dose of Effexor, headache, pain in both shoulders and neck, red-hot nerve pain extending from my right hand all the way up my arm to my neck where the cervical spine joins the skull, increased resting pulse rate (100bpm instead of normal rate between 70-80bpm), elevated blood pressure (135/90 instead of normal 117/78), extreme fatigue, insomnia, fever (around 100 degrees instead of normal 97.5), and flu-like symptoms. Most of these symptoms subsided after 12-24 hours, but headache, joint pain in shoulders and neck, and fatigue have continued (now a week since 2nd dose).
This spontaneous report was received from an office manager (certified medical assistant) refers to a nursing mother of unknown age. On 21-NOV-2013 the nursing mother was vaccinated with first dose of GARDASIL (dose, LOT # unknown). No adverse effects reported. The patient sought medical attention via office visit on an unspecified date. No treatment was given. Additional information has been requested.
64 yo female patient came in for a flu shot. We processed her paperwork for regular dose Fluzone. The immunizer accidentally grabbed Fluzone HD from the refrigerator and administered it to the patient. The patient was informed of the error approximately 5 minutes after administration. She was informed to contact both us (the administering pharmacy) and her physician if she experiences any side effects.
Extremely painful injection site. Redness. Fatigue/muscle aches/fever like symptoms.
Vomiting, fever and irritability. Sent to ER, dx with allergic reaction to vaccine.
Face tingling withing 30 minutes of shot. Then burning, swelling and rash on face and neck withing 10 hours of shot.  Then lip swelling, and throat itching withing 11 hours.  Took Benadryl over the weekend.
dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) had not resolved. Not Provided          No concomitant medication was reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: No specific follow-up information recorded.
Information has been received from a certified medical assistant for GARDASIL, a Pregnancy Registry Product, concerning a 24 year old female patient with no pertinent medical history and no drug reactions or allergies who on 14-MAR-2011 was vaccinated with the 1st dose of GARDASIL 0.5 ml, IM in the right deltoid (lot # 666597/0768Z and expiration date 17-OCT-2012. There was no concomitant medication. The medical assistant reported that on 13-MAY-2011 the patient was vaccinated with the second dose of GARDASIL (dose, route and lot # not reported) and was pregnant. On the date of this vaccination, a pregnancy test was taken prioir to the administrtaion of GARDASIL and it was negative. The patient came into the office on 03-JUN-2011 due to amenorrhea and a urine test confirmed that the patient was pregnant. The patient came into the office on 08-JUN-2011 for beta blood work pane. No adverse effects. Follow up information has been received from a medical assistant via a complete pregnancy questionnaire concerning the 24 year old female patient who on 13-MAY-2011 was vaccinated with the second dose of GARDASIL (lot #666597/0768Z). Concomitant medications included prenatal vitamins (unspecified) daily, for prescription given on 03-JUN-2011. The medical assistant reported that the estimated conception date was approximately on 10-MAY-2011. Prenatal laboratory tests included an ultrasound on 08-JUN-2011 for pregnancy viability and dates which showed a live fetus of 6 and 4/7 weeks. The patient's last menstrual period was 26-APR-2011, and the estimated delivery date would be 31-JAN-2012. Follow up information has been received from the medical assistant via pregnancy questionnaire concerning the patient who on 12-JAN-2012 delivered a normal female baby at 37 4/7 weeks with no congenital anomalies or other complications or abnormalities. The apgar score was 9/9.5. Concomitant therapy included FLALGYL and COMPAZINE. The medical assistant reported that hte patient did not have any complication during pregnancy. The patient had gestational hypertension during labor and she also experienced vaginal bacterial infection during pregnancy. A chest X-ray on 06-APR-2011 (results not provided). At the time of the report the patient's outcome from gestational hypertension and vaginal bacterial infection was unknown.
On 11/29/21, patient stated that on 11/17/21, 12 days after receiving the Moderna booster, he developed hives and itching all over his body which continues to present time.  He has found some relief from taking Benedryl, but the itching and hives are severe if not taking Benedryl.  No other symptoms are present.  Patient is in good general health condition.  Nurse advised him to contact his healthcare provider.  .
DAY AFTER VACCINATION, DEVELOPED SLIGHT MUSCLE ACHES IN UPPER BACK AND LOW GRAD FEVER (99.6) FOR A FEW HOURS. RESOLVED BY 1/2/21
It started off with severe fever throughout 27th night. I had a breaking headache along with it. On the following day (06/28), the fever subsided and the headache was less painful. When I went to Urgent Care on the following day (06/28), my body temperature was 99.5 F. I had itchy feeling all over the body. I also had blisters all over my body. The doctor also noted that "lymph node around neck was swollen", and subsequently ordered blood test to get CBC count. The headache was moderate for the following 4 days after which my head started to feel normal. A second vaccine was given on 07/13/2015. The itching started again, after 2 to 3 days of vaccination. It still continues to itch. I'm currently waiting to see if the itch will subside anytime soon. Wondering how long it will take for it to stop.
COPD flareup; Symptoms of coughing; Trouble breathing; knee pain; Experienced body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD flareup), COUGH (Symptoms of coughing), DYSPNOEA (Trouble breathing), ARTHRALGIA (knee pain) and MYALGIA (Experienced body aches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 030M20A) for COVID-19 vaccination.     The patient's past medical history included Knee replacement (left knee replacement in 2015) in 2015.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD flareup), COUGH (Symptoms of coughing), DYSPNOEA (Trouble breathing), ARTHRALGIA (knee pain) and MYALGIA (Experienced body aches). The patient was treated with HYDROMORPHONE at a dose of 2 mg and CORTISONE at an unspecified dose and frequency. At the time of the report, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD flareup), COUGH (Symptoms of coughing), DYSPNOEA (Trouble breathing), ARTHRALGIA (knee pain) and MYALGIA (Experienced body aches) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information  provided was Corticosteroids.  The action taken with mRNA-1273 with the events was considered as not applicable  For mRNA-1273 (Moderna COVID-19 Vaccine) (intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-114424 (Patient Link).
Significant/ongoing chills and shakes the day after 2nd dose of Moderna Covid vaccine, for 6 hours.   A very noticeable headache the entire day as well.
Leg pain, tingling, burning... chronic headaches and vertigo, high blood pressure and reoccurring subconjunctival hemorrhage in eyes.
I have what's been described as COVID arm. A red itchy welt about 2 inches wide and 3 inches long developed last night.
On the 4th hour I was sleepy and fatigue, 3pm, went to bed at 11pm, woke up at 2am extremely dizzy and the room was fiercely spinning and couldn?t get up. I tried going back to sleep and when trying to move the room spined drastically slowly sat up and went to the bathroom and laid back down and it started again, each duration lasted 10 seconds and it caused me to have 3 BMs in the next3 hours, couldn?t sleep but I have a tightness around my head and sleepiness and last event was 7am, when got up I had diarrhea and and had dry heaves that lasted 5 minutes and now fatigued and hot feeling around my eyes. My stomach feels stressed and tired and weak
Extreme dizziness, mental fog, and abnormal heavy uterine bleeding and shedding of clots, began to notice spotting 30-60 minutes post-vaccine, bleeding has grown progressively worse. 5 weeks postpartum, exclusively breastfeeding, no menstruation should be happening at this time.  Arm became very itchy 5 hours post-vaccine, itching improved but continues to be mildly itchy.
Started feeling, weakness, numbness and tingling in my feet, 2 days before I walked 5.5 miles, that after one mile I started feeling tired.
Pain in right arm; pain when she lifts her right arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st May 2019, the patient received the 1st dose of Shingrix. On 31st May 2019, less than a day after receiving Shingrix, the patient experienced pain in arm and pain upon movement. The patient was treated with naproxen (Aleve) and non-drug therapy (Heat Therapy). On an unknown date, the outcome of the pain in arm and pain upon movement were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and pain upon movement to be related to Shingrix.  Additional details were provided as follows:  The patient received Shingrix in her right upper arm and the pain started the same day of the vaccination, and then the pain increased and at the time of reporting  the pain was steady.  The patient had pain when she lifted her right arm. The patient had been taking Aleve and applying heat but the pain had not resolved.  The patient had been following up with her physician. The patient did not know the lot no, expiration, or the route of  administration.  The reporter consented to follow up.
Body aches at 10:00 pm next morning fever 100.7 at 4:00pm feel better next day
This spontaneous report was received from a company representative and refers to her 18 year old son. No information was provided regarding the patient's concurrent conditions, medical history or concomitant medications. On an unknown date, the patient was vaccinated with GARDASIL 9 for prophylaxis (dose, route of administration, lot number and expiration date were not reported). On an unknown date, the patient's injection site was red and inflamed (injection site inflammation and injection site erythema). The outcome of injection site inflammation and injection site erythema and the causal relationship between the aforementioned events and therapy with GARDASIL 9 was not reported.
This spontaneous report was received from a medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 07-JUL-2017, the patient was vaccinated with an expired dose of RECOMBIVAX HB injection, lot # K024553, expiration date 15-APR-2017 (dose, route and site of administration were not reported) for prophylaxis. The administered dose of vaccine also underwent a temperature excursion (no details provided). No adverse effects were reported. No additional information was provided. Additional information has been requested.
Multiple rashes that began 24 hours later. The rash is on one lower part of arm upper area near wrist, another on leg above the knee, and on the middle area of calf.; This is a spontaneous report from a contactable consumer.   A 59-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 14Apr2021 at 12:30 at the age of 59 years-old (Batch/Lot Number: EW0162) as SINGLE DOSE for covid-19 immunisation  .  Medical history included an allergy to shellfish and high cholesterol.  There were no other vaccines in the past 4 weeks.    There were no concomitant medications.  On 15Apr2021, at 0700, the patient experienced multiple rashes that began 24 hours later (after vaccination received during an unspecified hospitalization). The rash was on one lower part of arm upper area near wrist, another on leg above the knee, and on the middle area of calf. The outcome of the event was not recovered.
Information has been received from a nurse practitioner concerning a 15 year old female with no medical history or drug allergies who on 11-NOV-2010 was vaccinated IM with a first 0.5 ml dose of GARDASIL (Lot # 666929/0331Z). Secondary suspect therapy included a dose of VARIVAX (therapy route and lot # not reported) and a dose of flu vaccine (manufacturer unspecified) both given on 11-NOV-2010. Concomitant therapy included MENACTRA, HAVRIX and ADACEL all given on 11-NOV-2010. On 11-NOV-2010 the patient who received Dose 1 of GARDASIL fainted 10 minutes after administration. Patient had received other vaccinations during the same visit. On 11-NOV-2010 the patient recovered. No lab diagnostics studies performed. The patient sought unspecified medical attention. Additional information has been requested.
STUDENT FAINTED AND OR HAD A SEIZURE AFTER RECEIVING H1N1 VACCINE AT SCHOOL. STUDENT EPISODE APPROX 20 SECONDS ARMS TURNED INWARD AND STIFFNESS AFTER FALLING, URINARY INCONTINENCE OCCURRED.  STUDEN QUICKLY REGAINED CONSCIOUSNESS, ALERT AND AMBULATORY.  ACCORDING TO STUDENT: NO HISTORY OF SEIZURE.  PARENTS WILL FOLLOW UP WITH DOCTOR. VACCINATIONS GIVEN AT SCHOOL.
Post vax, the pt became cranky and had a fever of 104F by evening. She was brought to the hospital and a lumbar tap was (+) for viral meningitis.
Body aches and debilitating headache.  Lasted approximately 12-24 hours.  Took 1000mg Tylenol twice to manage symptoms around hour 8 and 14.
States 12-14 hours after immunization on 8-7-09; she experienced redness and inflammation at injection site, pain from ear down to wrist,fever,nausea,stomache ache,headache,and joint discomfort. Unable to function and bedbound for 1 day. General health gradually improving and symptoms decreasing. No meds have been taken for relief since administration of TDAP.
Initial report received from a consumer on 07 November 2008. A 46-year-old male patient had received a dose of FLUZONE (lot number U2810AA, route and site of administration not reported) on 06 November 2008 and within one hour, his eyes became itchy, face became red and he felt like his throat was closing. The patient used his asthma inhaler with some benefit. The patient also complained of fever of 102 degrees Fahrenheit, chills and vomiting that evening. On the day of the report, patient outcome was "not recovered". The patient reported feeling better although "not great", and indicated that he felt very tired. Documents held by sender: none
Information has been received from a physician concerning a patient of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On an unspecified date in 2014, the patient was vaccinated with the first dose of GARDASIL (dose, route, anatomical location, lot number and expiration date were not reported). Then on 28-NOV-2016, the patient was vaccinated with the second dose of GARDASIL (dosage schedule, route, anatomical location, lot number and expiration date were not reported). Other suspect and concomitant medications were not provided. No symptoms were reported. No product quality complaint was involved. Additional information is not expected because the reporter did not consent for further follow up.
High pitch scream, very high fever, reduce eye contact. Red rash 3 days duration. ER visit (call doctor), fever reducer.
A vice like head pain that hasn't gone away. Makes thinking hard, light sensitive and exhaustion. Advil doesn't help. Feels like my brain is swollen and I can't think. I wake up with it, nothing changes the feeling. Massive herpes outbreak. Haven't had one in 2 years.  Angry and emotional when I wasn't feeling this way before hand. Exhausted, sleeping 12-14 hours a day with naps in between. Extreme lethargy.